Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Costanza Di Chiara, Daniele Mengato, Marica De Pieri, Germana Longo, Elisa Benetti, Francesca Venturini, Carlo Giaquinto, Daniele Donà
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-03-01
Colecção:Children
Assuntos:
sotrovimab
children
viral-neutralizing monoclonal antibodies
off-label
SARS-CoV-2
COVID-19
Acesso em linha:https://www.mdpi.com/2227-9067/9/4/451
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados